Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Union leaders will meet executives at AstraZeneca today to try to convince Britain's second-biggest drugmaker to reverse plans to close its R&D site in Cheshire and move almost 2,000 jobs. AstraZeneca wants to move its R&D hub from Alderley Park in Cheshire to Cambridge by 2016. The pharma giant is suffering as a string of drugs run out of patent, with few new hopes in the pipeline to replace those lost revenues. Its two top-selling drugs, Nexium ulcer pills and the Crestor cholesterol-buster, see their US patents expire in 2014 and 2016.
Help employers find you! Check out all the jobs and post your resume.
Union leaders will meet executives at AstraZeneca today to try to convince Britain's second-biggest drugmaker to reverse plans to close its R&D site in Cheshire and move almost 2,000 jobs. AstraZeneca wants to move its R&D hub from Alderley Park in Cheshire to Cambridge by 2016. The pharma giant is suffering as a string of drugs run out of patent, with few new hopes in the pipeline to replace those lost revenues. Its two top-selling drugs, Nexium ulcer pills and the Crestor cholesterol-buster, see their US patents expire in 2014 and 2016.
Help employers find you! Check out all the jobs and post your resume.
